| GILD |
Gilead Sciences, Inc. |
115.37B |
8.63% |
|
|
|
|
|
92.57 |
1.62% |
36.85% |
46.92% |
|---|
| AMGN |
Amgen Inc. |
141.58B |
8.04% |
|
|
|
|
|
263.38 |
0.84% |
25.97% |
20.88% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
75.85B |
7.57% |
|
|
|
|
|
701.85 |
-0.90% |
34.78% |
72.04% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
102.31B |
7.33% |
|
|
|
|
|
397.27 |
0.16% |
52.65% |
97.77% |
|---|
| AZN |
AstraZeneca PLC |
202.63B |
3.80% |
|
|
|
|
|
65.35 |
1.41% |
24.74% |
48.78% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
31.66B |
3.16% |
|
|
|
|
|
245.44 |
2.75% |
37.31% |
31.83% |
|---|
| ILMN |
Illumina, Inc. |
21.57B |
2.15% |
|
|
|
|
|
136.02 |
1.51% |
45.78% |
35.98% |
|---|
| BIIB |
Biogen Inc. |
21.34B |
2.13% |
|
|
|
|
|
146.47 |
-0.62% |
33.95% |
70.80% |
|---|
| ARGX |
argenx SE |
37.66B |
2.01% |
|
|
|
|
|
623.82 |
-0.35% |
36.87% |
29.93% |
|---|
| UTHR |
United Therapeutics Corporation |
16.05B |
1.60% |
|
|
|
|
|
359.58 |
-0.16% |
N/A |
N/A |
|---|
| MRNA |
Moderna, Inc. |
15.16B |
1.51% |
|
|
|
|
|
39.39 |
-0.43% |
88.72% |
99.14% |
|---|
| VTRS |
Viatris Inc. |
14.94B |
1.49% |
|
|
|
|
|
12.52 |
3.22% |
30.30% |
30.97% |
|---|
| SNY |
Sanofi |
119.62B |
1.43% |
|
|
|
|
|
47.71 |
0.44% |
23.09% |
29.40% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
13.71B |
1.37% |
|
|
|
|
|
135.42 |
0.34% |
36.61% |
2.44% |
|---|
| INCY |
Incyte Corporation |
13.26B |
1.32% |
|
|
|
|
|
68.84 |
2.65% |
52.75% |
75.41% |
|---|
| SMMT |
Summit Therapeutics Inc. |
13.17B |
1.32% |
|
|
|
|
|
17.87 |
-2.88% |
76.99% |
10.72% |
|---|
| INSM |
Insmed Incorporated |
12.60B |
1.26% |
|
|
|
|
|
70.44 |
1.48% |
61.36% |
12.19% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
12.51B |
1.25% |
|
|
|
|
|
65.66 |
1.02% |
36.49% |
36.43% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.36B |
1.13% |
|
|
|
|
|
118.97 |
-0.42% |
41.48% |
17.53% |
|---|
| BNTX |
BioNTech SE |
27.11B |
1.11% |
|
|
|
|
|
113.08 |
1.56% |
45.00% |
52.02% |
|---|
| RPRX |
Royalty Pharma plc |
11.07B |
1.11% |
|
|
|
|
|
24.92 |
2.64% |
30.67% |
33.89% |
|---|
| PCVX |
Vaxcyte, Inc. |
10.78B |
1.08% |
|
|
|
|
|
86.53 |
0.37% |
65.35% |
30.72% |
|---|
| MEDP |
Medpace Holdings, Inc. |
10.48B |
1.05% |
|
|
|
|
|
337.28 |
0.64% |
40.42% |
31.72% |
|---|
| EXEL |
Exelixis, Inc. |
9.51B |
0.95% |
|
|
|
|
|
33.29 |
-1.16% |
38.11% |
33.80% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
8.85B |
0.88% |
|
|
|
|
|
83.45 |
-0.82% |
41.43% |
17.81% |
|---|
| ROIV |
Roivant Sciences Ltd. |
8.42B |
0.84% |
|
|
|
|
|
11.57 |
0.61% |
45.10% |
54.92% |
|---|
| ASND |
Ascendis Pharma A/S |
8.15B |
0.82% |
|
|
|
|
|
136.38 |
-0.99% |
42.25% |
52.35% |
|---|
| BGNE |
BeiGene, Ltd. |
20.02B |
0.78% |
|
|
|
|
|
176.50 |
1.02% |
N/A |
N/A |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.43B |
0.74% |
|
|
|
|
|
122.97 |
0.10% |
32.47% |
28.35% |
|---|
| RVMD |
Revolution Medicines, Inc. |
8.03B |
0.74% |
|
|
|
|
|
44.06 |
1.78% |
47.34% |
3.99% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
6.73B |
0.67% |
|
|
|
|
|
308.44 |
5.12% |
55.96% |
15.26% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
5.97B |
0.60% |
|
|
|
|
|
46.96 |
-0.76% |
45.48% |
38.93% |
|---|
| CYTK |
Cytokinetics, Incorporated |
5.77B |
0.58% |
|
|
|
|
|
48.87 |
4.56% |
62.31% |
15.38% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.73B |
0.57% |
|
|
|
|
|
90.14 |
1.36% |
56.46% |
30.27% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.63B |
0.56% |
|
|
|
|
|
35.63 |
0.11% |
47.85% |
72.37% |
|---|
| NUVL |
Nuvalent, Inc. |
5.98B |
0.55% |
|
|
|
|
|
84.22 |
-0.50% |
41.41% |
31.23% |
|---|
| TEM |
Tempus AI Inc |
|
0.54% |
|
|
|
|
|
|
|
|
|
|---|
| BBIO |
BridgeBio Pharma, Inc. |
5.01B |
0.50% |
|
|
|
|
|
26.49 |
1.07% |
55.19% |
13.99% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
4.97B |
0.50% |
|
|
|
|
|
53.60 |
1.63% |
49.15% |
47.46% |
|---|
| ALKS |
Alkermes plc |
4.81B |
0.48% |
|
|
|
|
|
29.71 |
-0.87% |
46.26% |
66.15% |
|---|
| KRYS |
Krystal Biotech, Inc. |
4.74B |
0.47% |
|
|
|
|
|
164.83 |
2.49% |
56.31% |
46.00% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.40B |
0.44% |
|
|
|
|
|
90.73 |
1.10% |
117.03% |
96.34% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
4.19B |
0.42% |
|
|
|
|
|
44.78 |
6.39% |
79.53% |
14.14% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
4.13B |
0.41% |
|
|
|
|
|
33.21 |
0.21% |
68.72% |
25.79% |
|---|
| ADMA |
ADMA Biologics, Inc. |
4.11B |
0.41% |
|
|
|
|
|
17.40 |
-2.79% |
68.48% |
16.62% |
|---|
| ACLX |
Arcellx, Inc. |
4.08B |
0.41% |
|
|
|
|
|
75.54 |
0.44% |
59.95% |
42.57% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
4.08B |
0.41% |
|
|
|
|
|
44.22 |
1.73% |
63.75% |
41.25% |
|---|
| GH |
Guardant Health, Inc. |
3.91B |
0.39% |
|
|
|
|
|
31.67 |
1.73% |
52.87% |
31.59% |
|---|
| IMVT |
Immunovant, Inc. |
3.80B |
0.38% |
|
|
|
|
|
25.86 |
0.78% |
49.43% |
44.59% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.80B |
0.38% |
|
|
|
|
|
31.82 |
2.48% |
62.95% |
21.24% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
3.57B |
0.36% |
|
|
|
|
|
46.24 |
2.19% |
78.18% |
26.50% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.48B |
0.35% |
|
|
|
|
|
40.72 |
0.83% |
58.99% |
29.19% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
3.45B |
0.34% |
|
|
|
|
|
56.12 |
1.15% |
50.53% |
14.31% |
|---|
| NVCR |
NovoCure Limited |
3.33B |
0.33% |
|
|
|
|
|
30.80 |
1.32% |
68.36% |
14.20% |
|---|
| ALVO |
Alvotech |
3.59B |
0.32% |
|
|
|
|
|
11.91 |
-1.65% |
N/A |
N/A |
|---|
| VCYT |
Veracyte, Inc. |
3.17B |
0.32% |
|
|
|
|
|
40.89 |
4.66% |
77.20% |
38.59% |
|---|
| VRNA |
Verona Pharma plc |
3.44B |
0.31% |
|
|
|
|
|
42.02 |
1.94% |
67.19% |
14.29% |
|---|
| DNLI |
Denali Therapeutics Inc. |
3.09B |
0.31% |
|
|
|
|
|
21.45 |
-0.19% |
64.50% |
52.72% |
|---|
| JANX |
Janux Therapeutics, Inc. |
3.28B |
0.30% |
|
|
|
|
|
56.83 |
0.14% |
63.39% |
10.59% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
2.95B |
0.29% |
|
|
|
|
|
38.63 |
-0.69% |
42.31% |
48.27% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
2.93B |
0.29% |
|
|
|
|
|
9.80 |
0.72% |
51.14% |
50.18% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
2.91B |
0.29% |
|
|
|
|
|
30.78 |
-0.06% |
89.24% |
14.36% |
|---|
| MRUS |
Merus N.V. |
2.87B |
0.29% |
|
|
|
|
|
41.85 |
-0.57% |
65.96% |
15.68% |
|---|
| TWST |
Twist Bioscience Corporation |
2.85B |
0.28% |
|
|
|
|
|
47.94 |
9.90% |
67.40% |
23.67% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.81B |
0.28% |
|
|
|
|
|
16.87 |
0.84% |
53.83% |
32.25% |
|---|
| LEGN |
Legend Biotech Corporation |
6.25B |
0.28% |
|
|
|
|
|
34.08 |
0.18% |
63.56% |
57.73% |
|---|
| VCEL |
Vericel Corporation |
2.79B |
0.28% |
|
|
|
|
|
56.50 |
2.82% |
52.61% |
36.15% |
|---|
| VERA |
Vera Therapeutics, Inc. |
2.70B |
0.27% |
|
|
|
|
|
42.60 |
1.31% |
53.85% |
14.67% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
2.65B |
0.26% |
|
|
|
|
|
35.59 |
2.33% |
84.36% |
64.23% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
2.63B |
0.26% |
|
|
|
|
|
40.66 |
3.88% |
67.80% |
52.06% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.47B |
0.25% |
|
|
|
|
|
41.49 |
4.93% |
68.97% |
27.99% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
2.44B |
0.24% |
|
|
|
|
|
23.99 |
-1.28% |
145.07% |
47.01% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.42B |
0.24% |
|
|
|
|
|
19.45 |
-0.26% |
54.48% |
47.43% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.59B |
0.24% |
|
|
|
|
|
7.78 |
0.39% |
560.06% |
32.47% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.40B |
0.24% |
|
|
|
|
|
29.01 |
8.04% |
71.59% |
58.49% |
|---|
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.72B |
0.24% |
|
|
|
|
|
25.50 |
0.16% |
60.33% |
5.54% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.31B |
0.23% |
|
|
|
|
|
6.03 |
-0.99% |
112.76% |
50.51% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
2.25B |
0.22% |
|
|
|
|
|
7.38 |
2.22% |
238.62% |
18.12% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
2.21B |
0.22% |
|
|
|
|
|
25.61 |
3.31% |
75.81% |
78.58% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
2.17B |
0.22% |
|
|
|
|
|
114.64 |
0.61% |
44.58% |
43.84% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
2.79B |
0.21% |
|
|
|
|
|
47.71 |
1.47% |
54.06% |
48.74% |
|---|
| GERN |
Geron Corporation |
2.11B |
0.21% |
|
|
|
|
|
3.49 |
-4.64% |
60.17% |
10.38% |
|---|
| WVE |
Wave Life Sciences Ltd. |
2.06B |
0.21% |
|
|
|
|
|
13.51 |
2.43% |
104.94% |
25.52% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
2.05B |
0.20% |
|
|
|
|
|
29.34 |
3.31% |
60.01% |
41.50% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
2.02B |
0.20% |
|
|
|
|
|
35.42 |
-1.09% |
65.52% |
63.71% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
2.02B |
0.20% |
|
|
|
|
|
52.91 |
1.75% |
95.92% |
66.61% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
1.99B |
0.20% |
|
|
|
|
|
41.51 |
0.92% |
65.33% |
43.01% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
1.96B |
0.20% |
|
|
|
|
|
34.28 |
1.15% |
88.99% |
84.41% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
1.96B |
0.20% |
|
|
|
|
|
35.43 |
-0.95% |
49.31% |
36.57% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
2.18B |
0.19% |
|
|
|
|
|
28.67 |
2.32% |
94.48% |
82.26% |
|---|
| IRON |
Disc Medicine, Inc. |
1.92B |
0.19% |
|
|
|
|
|
64.50 |
2.46% |
67.95% |
19.35% |
|---|
| MNKD |
MannKind Corporation |
1.89B |
0.19% |
|
|
|
|
|
6.85 |
8.73% |
64.11% |
41.80% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
1.88B |
0.19% |
|
|
|
|
|
39.14 |
-0.63% |
112.92% |
75.12% |
|---|
| IBRX |
ImmunityBio, Inc. |
1.91B |
0.18% |
|
|
|
|
|
2.6200 |
-1.87% |
196.53% |
22.37% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
1.75B |
0.18% |
|
|
|
|
|
14.99 |
6.24% |
102.23% |
14.03% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
1.75B |
0.18% |
|
|
|
|
|
10.85 |
3.33% |
404.13% |
97.37% |
|---|
| FTRE |
Fortrea Holdings Inc. |
1.73B |
0.17% |
|
|
|
|
|
19.26 |
4.11% |
95.10% |
69.62% |
|---|
| DVAX |
Dynavax Technologies Corporation |
1.67B |
0.17% |
|
|
|
|
|
12.72 |
-0.31% |
53.00% |
61.19% |
|---|
| GPCR |
Structure Therapeutics Inc. |
1.60B |
0.17% |
|
|
|
|
|
27.90 |
-6.91% |
89.69% |
23.83% |
|---|
| XNCR |
Xencor, Inc. |
1.69B |
0.16% |
|
|
|
|
|
24.13 |
0.50% |
97.87% |
20.59% |
|---|